These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33015771)

  • 1. Suppression of HAX-1 induced by miR-325 resensitizes bladder cancer cells to cisplatin-induced apoptosis.
    Li R; Zheng JZ; Huang X
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9303-9314. PubMed ID: 33015771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-100 Reverses Cisplatin Resistance in Breast Cancer by Suppressing HAX-1.
    Wu G; Zhou W; Pan X; Sun Y; Xu H; Shi P; Li J; Gao L; Tian X
    Cell Physiol Biochem; 2018; 47(5):2077-2087. PubMed ID: 29975932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIF-1α-dependent miR-424 induction confers cisplatin resistance on bladder cancer cells through down-regulation of pro-apoptotic UNC5B and SIRT4.
    Yu M; Ozaki T; Sun D; Xing H; Wei B; An J; Yang J; Gao Y; Liu S; Kong C; Zhu Y
    J Exp Clin Cancer Res; 2020 Jun; 39(1):108. PubMed ID: 32522234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-101 suppresses vascular endothelial growth factor C that inhibits migration and invasion and enhances cisplatin chemosensitivity of bladder cancer cells.
    Lei Y; Li B; Tong S; Qi L; Hu X; Cui Y; Li Z; He W; Zu X; Wang Z; Chen M
    PLoS One; 2015; 10(2):e0117809. PubMed ID: 25658842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery of miR-139-5p in Ovarian Cancer Reverses Cisplatin Resistance by Targeting C-Jun.
    Jiang Y; Jiang J; Jia H; Qiao Z; Zhang J
    Cell Physiol Biochem; 2018; 51(1):129-141. PubMed ID: 30439707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emodin enhances cisplatin-induced cytotoxicity in human bladder cancer cells through ROS elevation and MRP1 downregulation.
    Li X; Wang H; Wang J; Chen Y; Yin X; Shi G; Li H; Hu Z; Liang X
    BMC Cancer; 2016 Aug; 16():578. PubMed ID: 27485374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression.
    Daga M; Pizzimenti S; Dianzani C; Cucci MA; Cavalli R; Grattarola M; Ferrara B; Scariot V; Trotta F; Barrera G
    Phytomedicine; 2019 Mar; 56():156-164. PubMed ID: 30668336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer.
    Okamura S; Yoshino H; Kuroshima K; Tsuruda M; Osako Y; Sakaguchi T; Yonemori M; Yamada Y; Tatarano S; Nakagawa M; Enokida H
    BMC Cancer; 2021 Jan; 21(1):48. PubMed ID: 33430801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-367-3p directly targets RAB23 and inhibits proliferation, migration and invasion of bladder cancer cells and increases cisplatin sensitivity.
    Wei X; Jiang Y; Yang G; Chang T; Sun G; Chen S; Wu S; Liu R
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):17807-17821. PubMed ID: 37935937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
    Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
    Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-294 Promotes Cellular Proliferation and Motility through the PI3K/AKT and JAK/STAT Pathways by Upregulation of NRAS in Bladder Cancer.
    Li Y; Shan Z; Liu C; Yang D; Wu J; Men C; Xu Y
    Biochemistry (Mosc); 2017 Apr; 82(4):474-482. PubMed ID: 28371605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-203 Is a Prognostic Indicator in Bladder Cancer and Enhances Chemosensitivity to Cisplatin via Apoptosis by Targeting Bcl-w and Survivin.
    Zhang X; Zhang Y; Liu X; Fang A; Li P; Li Z; Liu T; Yang Y; Du L; Wang C
    PLoS One; 2015; 10(11):e0143441. PubMed ID: 26599571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enforced expression of miR-101 enhances cisplatin sensitivity in human bladder cancer cells by modulating the cyclooxygenase-2 pathway.
    Bu Q; Fang Y; Cao Y; Chen Q; Liu Y
    Mol Med Rep; 2014 Oct; 10(4):2203-9. PubMed ID: 25109742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-374a Inhibits Aggressive Tumor Biological Behavior in Bladder Carcinoma by Suppressing Wnt/β-Catenin Signaling.
    Chen X; Jia C; Jia C; Jin X; Gu X
    Cell Physiol Biochem; 2018; 48(2):815-826. PubMed ID: 30032142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-132 reverses cisplatin resistance and metastasis in ovarian cancer by the targeted regulation on Bmi-1.
    Zhang XL; Sun BL; Tian SX; Li L; Zhao YC; Shi PP
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3635-3644. PubMed ID: 31114988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy.
    Chen J; Wang L; Tang Y; Gong G; Liu L; Chen M; Chen Z; Cui Y; Li C; Cheng X; Qi L; Zu X
    J Exp Clin Cancer Res; 2016 Jan; 35():2. PubMed ID: 26733306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA-21 modulates cell proliferation and sensitivity to doxorubicin in bladder cancer cells.
    Tao J; Lu Q; Wu D; Li P; Xu B; Qing W; Wang M; Zhang Z; Zhang W
    Oncol Rep; 2011 Jun; 25(6):1721-9. PubMed ID: 21468550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-98 promotes drug resistance and regulates mitochondrial dynamics by targeting LASS2 in bladder cancer cells.
    Luan T; Fu S; Huang L; Zuo Y; Ding M; Li N; Chen J; Wang H; Wang J
    Exp Cell Res; 2018 Dec; 373(1-2):188-197. PubMed ID: 30463687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR‑214 reduces cisplatin resistance by targeting netrin‑1 in bladder cancer cells.
    Liu J; Bi J; Li Z; Li Z; Liu X; Kong C
    Int J Mol Med; 2018 Mar; 41(3):1765-1773. PubMed ID: 29328435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-202 Enhances the Anti-Tumor Effect of Cisplatin on Non-Small Cell Lung Cancer by Targeting the Ras/MAPK Pathway.
    Sun W; Ping W; Tian Y; Zou W; Liu J; Zu Y
    Cell Physiol Biochem; 2018; 51(5):2160-2171. PubMed ID: 30522099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.